Translational spotlight on immuno-oncology innovation
Mechanisms in BioCentury’s Distillery extend beyond checkpoints
Immuno-oncology innovations published by academics over the last year include non-checkpoint targets that modulate T cell killing thresholds, and strategies to decrease immunosuppressive conditions in the tumor microenvironment.
Save for a few bright spots, industry momentum in immuno-oncology has shown signs of slowing down, but academic investigators are still discovering new targets and agents to drive antitumor immunity...